Defeating Economic Loss Claims In Pharma Class Actions

Law360, New York (October 23, 2013, 1:40 PM EDT) -- Where product liability actions or government investigators have targeted a prescription drug, class actions follow alleging that patients are entitled to a refund of what they paid for the medicine. The theory of these parasitic class actions is that the manufacturer misrepresented the safety or efficacy of the medicine, thereby violating consumer protection statutes.

But a patient should not get her money back if the medicine worked and caused no physical injury. Or should a patient get her money back where she cannot show that, but...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.